Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
My study aims to directly compare the efficacy and safety of Budesonide MMX versus
Prednisolone in the management of mild to moderate cases of ulcerative colitis.